We asked a group of seasoned Bay Area-based stalwarts about what’s on the horizon for the coming year.
Ken Schultz, M.D., a seasoned biopharma executive with two decades of global M&A dealmaking expertise, provides an exclusive insider’s view of transactions he’s led during his storied career.
On September 25 SS&C Intralinks held its fifth annual M&A Insights Panel at the Rosewood in Menlo Park, CA. The focus of this year’s discussion was around corporate venture capital (CVC) and what role CVCs play to drive corporate innovation and growth.
In a candid video interview, Tom McGee, VP of corporate development, shares some of the key ingredients.
The 2018 World Cup has been exciting so far. In my view, however, the most riveting play is yet to come. Not the finals. I’m talking about the World Cup heading to North America in 2026.
Starting to formulate a plan to map out post-merger integration goals and milestones can be a daunting task at first. Here are a few tips to help.